Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Topics Community

Article

Plasma genetic and genomic abnormalities predict treatment response and clinical outcome in advanced prostate cancer

15 Apr 2015

Abstract excerpt

// Shu Xia 1,2,* , Manish Kohli 3,* , Meijun Du 2 , Rachel L. Dittmar 2 , Adam Lee 4 , Debashis Nandy 3 , Tiezheng Yuan 2 , Yongchen Guo 2 , Yuan Wang 2 , Michael R. Tschannen 5 , Elizabeth Worthey 5 , Howard Jacob 5 , William See 6 , Deepak Kilari 6 , Xuexia Wang 7 , Raymond L. Hovey 8 , Chiang-Ching Huang 7 and Liang Wang 2 1 Department of Oncology, Tongji Hospital of Tongji Medical College, Huazhong University...

Source

Identifiers

PMID: 25915538
DOI: 10.18632/oncotarget.3845

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Plasma genetic and genomic abnormalities predict treatment response and clinical outcome in advanced prostate cancerPMID 25915538Read ↗

Copy number variations in urine cell free DNA as biomarkers in advanced prostate cancerSemantic proximity Read ↗

Genomic Profiling of Prostate Cancer: An Updated ReviewSemantic proximity Read ↗

Genomic and Phenotypic Biomarkers for Precision Medicine Guidance in Advanced Prostate Cancer.Semantic proximity Read ↗

Integrative genomic and epigenomic profiling in plasma and urinary cell-free DNA improves early risk stratification of newly diagnosed prostate cancerSemantic proximity Read ↗

The Genomic and Molecular Pathology of Prostate Cancer: Clinical Implications for Diagnosis, Prognosis, and TherapySemantic proximity Read ↗

Future directions for precision oncology in prostate cancerSemantic proximity Read ↗

DNA alterations in the tumor genome and their associations with clinical outcome in prostate cancer.Semantic proximity Read ↗

Genomic analysis in active surveillance: predicting high-risk disease using tissue biomarkers.Semantic proximity Read ↗

Targeted next-generation sequencing of advanced prostate cancer identifies potential therapeutic targets and disease heterogeneity.Semantic proximity Read ↗

Genomic, pathological, and clinical heterogeneity as drivers of personalized medicine in prostate cancerSemantic proximity Read ↗

Cell-Free DNA Detection of Tumor Mutations in Heterogeneous, Localized Prostate Cancer Via Targeted, Multiregion Sequencing.Semantic proximity Read ↗

Circulating tumor DNA and tissue complementarily detect genomic alterations in metastatic hormone-sensitive prostate cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.